Neumous

Company

Neumous develops one asset, in human trials (NMS-01 in Alzheimer's disease). Mostly device.

1
Asset
Furthest stage
Human trials
1
Trial
2
Signals

Pipeline

1
  • NMS-01

    Uses focused ultrasound to transiently open the blood-brain barrier.

    Human trials, Device, Alzheimer's disease, blood brain barrier

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials1
  • Signals2
  • Similar companies6

Intelligence